TWD 93.3
(0.32%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 196.1 Million TWD | 41.94% |
2022 | 141.14 Million TWD | 18.01% |
2021 | 119.6 Million TWD | 34.64% |
2020 | 88.83 Million TWD | 1176.22% |
2019 | -8.25 Million TWD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 38.95 Million TWD | 0.0% |
2024 Q1 | 38.95 Million TWD | -27.46% |
2023 Q2 | 44.35 Million TWD | 0.0% |
2023 Q4 | 53.69 Million TWD | 0.0% |
2023 FY | 200.33 Million TWD | 41.94% |
2023 Q1 | 44.35 Million TWD | 7.28% |
2023 Q3 | 53.69 Million TWD | 21.06% |
2022 Q3 | 41.34 Million TWD | 0.0% |
2022 FY | 141.14 Million TWD | 18.01% |
2022 Q4 | 41.34 Million TWD | 0.0% |
2021 FY | 119.6 Million TWD | 34.64% |
2020 FY | 88.83 Million TWD | 1176.22% |
2019 FY | -8.25 Million TWD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Allied Biotech Corporation | 88.71 Million TWD | -121.049% |
GeneFerm Biotechnology Co., Ltd. | 153.56 Million TWD | -27.699% |
Easywell Biomedicals, Inc. | -162.73 Million TWD | 220.501% |
TTY Biopharm Company Limited | 1.37 Billion TWD | 85.711% |
Synmosa Biopharma Corporation | 614.74 Million TWD | 68.1% |
Orient EuroPharma Co., Ltd. | 84.55 Million TWD | -131.924% |
Center Laboratories, Inc. | -79.26 Million TWD | 347.399% |
Tien Liang BioTech Co., Ltd. | 20.43 Million TWD | -859.586% |
Orient Pharma Co., Ltd. | 27.75 Million TWD | -606.594% |
InnoPharmax Inc. | -64.83 Million TWD | 402.443% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 105.57 Million TWD | -85.753% |
Excelsior Biopharma Inc. | -81.12 Million TWD | 341.718% |
DV Biomed Co., Ltd. | 173.54 Million TWD | -12.995% |
Foresee Pharmaceuticals Co., Ltd. | -1 Billion TWD | 119.462% |
Handa Pharmaceuticals, Inc. | 695.79 Million TWD | 71.816% |
UniPharma Co., Ltd. | -27.3 Million TWD | 818.187% |
Anxo Pharmaceutical Co., Ltd. | 53.15 Million TWD | -268.937% |
Alar Pharmaceuticals Inc. | 385.52 Million TWD | 49.134% |
Mercury Biopharmaceutical Corporation | -45.69 Million TWD | 529.199% |
Bioray Biotech Co., Ltd | -19.33 Million TWD | 1114.438% |
TSH Biopharm Corporation Limited | 63.63 Million TWD | -208.19% |